Generics Industry News Search
 |
|
|
|
|
|
|
December 2014 News Archive |
|
|
| |
|
IGI Laboratories today announced it has submitted an additional ANDA to the U.S. FDA, which brings the Company's total number of ANDA submissions in 2014 to eight...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Actavis today announced that it has launched a generic version of Intuniv (Guanfacine hydrochloride)...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Ranbaxy today announced the launch of Infimab (BOW015), the first Remicade (Infliximab) biosimilar in India...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Teva Pharmaceutical announces the launch of the generic equivalent to Exforge HCT (Amlodipine, Valsartan, hydrochlorothiazide)...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Teva Pharmaceutical, the company behind multiple sclerosis drug Copaxone (Glatiramer acetate injection), has been pursuing the US FDA's decision against approving a generic version of the drug, by Mylan...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Heritage announced the immediate availability of Furosemide injection...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Heritage announced the immediate availability of Felodipine extended-release tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Epirus today announced the launch of its first product, Infimab...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Perrigo today announced that it has received final approval from the FDA on its ANDA for Diclofenac sodium topical solution...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Sweden-based drug firm Meda Pharmaceuticals and Cipla have "sued" Apotex Inc and Apotex Corp in Federal District Court in Delaware in US to enforce patents of its allergy drug 'Dymista'...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The FDA admits it has been slow to issue guidance on biosimilar drugs that are expected to hit the U.S. market next year...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The top U.S. patent appeals court has upheld the dismissal of a lawsuit brought by Sandoz that sought to shield its planned version of Amgen's psoriasis and arthritis drug...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
GVK BIO allegedly manipulated the results of clinical trials of generic drugs it carried out on behalf of several European manufacturers, say some German media reports...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
In a landmark judgement for pharma sector, a US jury has ruled that AstraZeneca's patent litigation settlement for blockbuster drug Nexium with Ranbaxy was not anti-competitive...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Sandoz, a Novartis company, announced today Phase III data that
demonstrated similarity of its investigational biosimilar Filgrastim
compared to the US-licensed reference product, Amgen's Neupogen
(Filgrastim)...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Cubist Pharmaceuticals, the drugmaker being bought by Merck & Co.
for $8.4 billion, lost a bid to block Hospira from offering a generic
version of its top-selling Cubicin treatment for flesh-eating infections
beyond 2016...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Teva Canada announced today that Health Canada has approved its application for the generic version of Tarceva...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Supernus Pharmaceuticals today announced that on December 8, 2014 the Company received a Paragraph IV Notice Letter from Par Pharmaceutical advising...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
After more than a decade long wait, the revolutionary therapy that provided a new lease of life to millions of patients suffering from rheumatoid arthritis and other auto immune disorders globally will now be accessible to patients in India...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Supernus today announced that on December 9, 2014 the company received a Paragraph IV notice letter from TWi...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Teva announces the launch of the first FDA-approved generic equivalent to Celebrex...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Actavis today announced that it has launched a generic version of Celebrex...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan today announced the U.S. launch of its Celecoxib capsules...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Germany's drug regulator has banned the sale of 80 generic medicines...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Actavis today confirmed that Judge Robert Sweet of the U.S. District Court for the Southern District of New York has announced...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan today announced the U.S. launch of its Prednisolone sodium phosphate orally disintegrating tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Wilshire today confirmed that it has been sued by Allergan...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan today announced the U.S. launch of its Methocarbamol injection...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Lupin has launched the authorised generic for Searle's (a subsidiary of Pfizer) Celebrex capsules (Celecoxib) 50 mg, 100 mg, 200 mg and 400 mg strengths...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Teva Pharmaceuticals on Thursday announced the availability of Levalbuterol inhalation solution...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
German drugmaker Bayer has failed in a last-ditch attempt to block the sale of a cheap generic version of its cancer drug Nexavar in India, after the country's Supreme Court ruled against it on Friday...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Daiichi Sankyo announced that its generics subsidiary, Daiichi Sankyo Espha, today launched nine new generic drugs with three new active ingredients...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Actavis today confirmed that it is filling an emergency appeal to the U.S. Court of Appeals for the Second Circuit seeking to...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Novartis' generic division, Sandoz, is having to recall one lot of its generic version of AstraZeneca's blood pressure drug Atacand...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Dr. Reddy's announced today that it has launched Valganciclovir tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Germany's drug regulator has said that its ban on the sale of 80 generic medicines subjected to clinical trials by India's GVK Biosciences will not be applicable for...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Teva has lost its 180 days exclusivity for the generic version of Pfizer's arthritis and chronic pain treatment...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Apotex announced today that the FDA has accepted for filing the company's application for Pegfilgrastim...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The Delhi High Court has reserved its verdict on a dispute between pharm firms Novartis and Cipla over manufacturing of the drug Indacaterol...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Lannett today announced that it has received approval from the FDA of its ANDA for Dorzolamide hydrochloride and Timolol maleate ophthalmic solution...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Putney announces today that it is launching Putney Carprofen chewable tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Breckenridge announced today that it has entered into a multi-product agreement with MSN Laboratories...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan today announced the U.S. launch of its Oestradiol transdermal system USP, 0.025 mg/day, 0.0375 mg/day...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan today announced the U.S. launch of its Estradiol Transdermal System USP...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Actavis and Adamas Pharmaceuticals today announced that the U.S.FDA has approved the ADA) for Namzaric, a fixed-dose combination (FDC) of Memantine hydrochloride extended-release, a NMDA receptor antagonist, and Donepezil hydrochloride, an acetylcholinesterase inhibitor...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Lupin announced today that it has received final approval for its Lamivudine tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
A comparison of two of the most disparate approved generic antiepileptic drugs found minimal differences when compared under rigorous testing procedures in people with epilepsy, according to research presented by a University of Cincinnati clinician-researcher
...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Lupin announced today that it has received tentative approval for its Darunavir ethanolate tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
|
|
Contribute
If you would like to contribute or publish your
company press releases at GenericsWeb, please
email us.
|
Home
